Guardant Health Stock Forecast

Stock Price Forecast

According to 26 analysts polled by S&P Global, Guardant Health stock has a consensus rating of "Strong Buy" and an average price target of $202.24. The average 1-year stock price forecast is 18.46% higher than the current stock price, while the lowest is $105 (-38.50%) and the highest is $240 (+40.57%).

Price Target: $202.24 (+18.46%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$105	$202.24	$203	$240
Change	-38.50%	+18.46%	+18.90%	+40.57%

Analyst Ratings

The average analyst rating for Guardant Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	16	19	19	19	20	21
Buy	4	5	5	5	5	4
Hold	1	0	0	0	0	0
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	22	25	25	25	26	26

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mark Massaro BTIG	BTIG	Buy Maintains $195 → $210	Buy	Maintains	$195 → $210	+23.00%	Oct 27, 2026
Max Masucci Roth MKM	Roth MKM	Buy Initiates $200	Buy	Initiates	$200	+17.14%	Oct 22, 2026
Kallum Titchmarsh Morgan Stanley	Morgan Stanley	Buy Maintains $200	Buy	Maintains	$200	+17.14%	Oct 20, 2026
Eve Burstein Bernstein	Bernstein	Buy Reiterates $210	Buy	Reiterates	$210	+23.00%	Oct 18, 2026
Casey Woodring J.P. Morgan	J.P. Morgan	Buy Maintains $195	Buy	Maintains	$195	+14.22%	Oct 14, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.36B

from 982.02M

38.41%

from 982.02M

Revenue Next Year

1.84B

from 1.36B

35.18%

from 1.36B

EPS This Year

-1.45

from -1.82

EPS Next Year

-0.38

from -1.45

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	373.65M	449.54M	563.95M	739.02M	982.02M	1.36B
Revenue Growth	30.32%	20.31%	25.45%	31.04%	32.88%	38.41%
Gross Profit	250.74M	293.21M	336.90M	449.22M	633.01M	882.61M
Gross Margin	67.11%	65.23%	59.74%	60.79%	64.46%	64.94%
Operating Income	-411.00M	-544.38M	-481.22M	-442.58M	-436.30M	-434.26M
Net Income	-405.67M	-654.59M	-479.45M	-436.37M	-416.28M	-423.77M
EPS	-	-	-	-	-1.82	-1.45
Free Cash Flow	-	-	-	-	-233.07M	-201.92M
No. Analysts	-	-	-	-	-	25

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	1.4B
Avg	1.4B
Low	1.3B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	42.6%
Avg	38.4%
Low	37.2%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-1.18
Avg	-1.45
Low	-1.81

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-